These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21265358)

  • 1. Does prophylactic subcutaneous heparin increase the risk of wound infection after colorectal surgery?
    Milanchi S; Nasseri Y; Westhout F; Murrell ZA; Fleshner PR
    Am Surg; 2010 Dec; 76(12):1412-5. PubMed ID: 21265358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep vein thrombosis prophylaxis increases perioperative surgical site infection in a prospective cohort of patients undergoing colorectal surgery.
    Short SS; Nasseri Y; Gangi A; Berel D; Fleshner P
    Am Surg; 2011 Oct; 77(10):1309-13. PubMed ID: 22127076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis and incisional surgical site infection following colorectal cancer surgery: an analysis of 330 cases.
    Lohsiriwat V; Lohsiriwat D
    J Med Assoc Thai; 2009 Jan; 92(1):12-6. PubMed ID: 19260237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.
    Marchetti M; Liberato NL; Ruperto N; Barosi G
    Haematologica; 1999 Aug; 84(8):730-7. PubMed ID: 10458700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery.
    Suehiro T; Hirashita T; Araki S; Matsumata T; Tsutsumi S; Mochiki E; Kato H; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(86-87):1636-9. PubMed ID: 19102358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin and related drugs for venous thromboembolism prophylaxis: subcutaneous or intravenous continuous infusion?
    Izadpanah M; Khalili H; Dashti-Khavidaki S; Mohammadi M
    J Comp Eff Res; 2015 Mar; 4(2):167-84. PubMed ID: 25825845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between the pattern of prophylactic antibiotic use and surgical site infection rate for major surgeries in Korea].
    Sakong P; Lee JS; Lee EJ; Ko KP; Kim CH; Kim Y; Kim YI
    J Prev Med Public Health; 2009 Jan; 42(1):12-20. PubMed ID: 19229120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical site infections in a "high outlier" institution: are colorectal surgeons to blame?
    Wick EC; Vogel JD; Church JM; Remzi F; Fazio VW
    Dis Colon Rectum; 2009 Mar; 52(3):374-9. PubMed ID: 19333034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
    Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
    J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of surgical site infections in general surgery in Italy.
    Fiorio M; Marvaso A; Viganò F; Marchetti F
    Infection; 2006 Dec; 34(6):310-4. PubMed ID: 17180584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of laparoscopic colorectal resection on surgical site infection.
    Poon JT; Law WL; Wong IW; Ching PT; Wong LM; Fan JK; Lo OS
    Ann Surg; 2009 Jan; 249(1):77-81. PubMed ID: 19106679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the incidence and predicted risk of early surgical site infections after breast reduction.
    Kompatscher P; von Planta A; Spicher I; Seifert B; Vetter S; Minder J; Beer GM
    Aesthetic Plast Surg; 2003; 27(4):308-14. PubMed ID: 15058556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetes mellitus on surgical site infections after colorectal and noncolorectal general surgical operations.
    Ata A; Valerian BT; Lee EC; Bestle SL; Elmendorf SL; Stain SC
    Am Surg; 2010 Jul; 76(7):697-702. PubMed ID: 20698373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
    Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
    Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.
    Suffoletta TJ; Jennings HR; Oh JJ; Stephens D; Poe KL
    Pharmacotherapy; 2008 Sep; 28(9):1133-9. PubMed ID: 18752384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
    Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
    Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.